Literature DB >> 17690245

Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription.

Dwayne A Bisgrove1, Tokameh Mahmoudi, Peter Henklein, Eric Verdin.   

Abstract

We have identified a conserved region in the C-terminal domain of bromodomain-containing protein 4 (BRD4) that mediates its specific interaction with positive transcription elongation factor b (P-TEFb). This domain is highly conserved in testis-specific bromodomain protein (BRDT) and Drosophila fs(1)h. Both BRDT and fs(1)h specifically interact with P-TEFb in mammalian cells, and this interaction depends on their C-terminal domains. Overexpression of the BRD4 P-TEFb-interacting domain disrupts the interaction between the HIV transactivator Tat and P-TEFb and suppresses the ability of Tat to transactivate the HIV promoter. Incubation of cells with a synthetic peptide containing the C-terminal domain of BRD4 interferes with transactivation of the HIV promoter by the Tat protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690245      PMCID: PMC1959443          DOI: 10.1073/pnas.0705053104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

2.  The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis.

Authors:  Anup Dey; Farideh Chitsaz; Asim Abbasi; Tom Misteli; Keiko Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-02       Impact factor: 11.205

3.  Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes.

Authors:  Yefei Han; Kara Lassen; Daphne Monie; Ahmad R Sedaghat; Shino Shimoji; Xiao Liu; Theodore C Pierson; Joseph B Margolick; Robert F Siliciano; Janet D Siliciano
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes.

Authors:  Jianxin You; Jennie L Croyle; Akiko Nishimura; Keiko Ozato; Peter M Howley
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

5.  The maternal-effect gene fsh is essential for the specification of the central region of the Drosophila embryo.

Authors:  D H Huang; I B Dawid
Journal:  New Biol       Date:  1990-02

6.  Isolation and characterization of sex-linked female-sterile mutants in Drosophila melanogaster.

Authors:  M Gans; C Audit; M Masson
Journal:  Genetics       Date:  1975-12       Impact factor: 4.562

Review 7.  You bet-cha: a novel family of transcriptional regulators.

Authors:  B Florence; D V Faller
Journal:  Front Biosci       Date:  2001-08-01

Review 8.  The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation.

Authors:  Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  J Biol Chem       Date:  2007-02-28       Impact factor: 5.157

9.  Acetylation-dependent chromatin reorganization by BRDT, a testis-specific bromodomain-containing protein.

Authors:  Christophe Pivot-Pajot; Cécile Caron; Jérôme Govin; Alexandre Vion; Sophie Rousseaux; Saadi Khochbin
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

10.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

View more
  192 in total

Review 1.  RNA polymerase II elongation control.

Authors:  Qiang Zhou; Tiandao Li; David H Price
Journal:  Annu Rev Biochem       Date:  2012-03-09       Impact factor: 23.643

2.  First drugs found to inhibit elusive cancer target.

Authors:  Melinda Wenner Moyer
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

3.  Kick-sTARting HIV-1 transcription elongation by 7SK snRNP deporTATion.

Authors:  Matjaz Barboric; Tina Lenasi
Journal:  Nat Struct Mol Biol       Date:  2010-08       Impact factor: 15.369

4.  A Minor Subset of Super Elongation Complexes Plays a Predominant Role in Reversing HIV-1 Latency.

Authors:  Zichong Li; Huasong Lu; Qiang Zhou
Journal:  Mol Cell Biol       Date:  2016-02-01       Impact factor: 4.272

Review 5.  BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs.

Authors:  Patricia Cristine Borck; Lian-Wang Guo; Jorge Plutzky
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

6.  BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.

Authors:  Qiming Duan; Sarah McMahon; Priti Anand; Hirsh Shah; Sean Thomas; Hazel T Salunga; Yu Huang; Rongli Zhang; Aarathi Sahadevan; Madeleine E Lemieux; Jonathan D Brown; Deepak Srivastava; James E Bradner; Timothy A McKinsey; Saptarsi M Haldar
Journal:  Sci Transl Med       Date:  2017-05-17       Impact factor: 17.956

7.  Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.

Authors:  Saumya Shree Gupta; Tobias Maetzig; Goedele N Maertens; Azar Sharif; Michael Rothe; Magdalena Weidner-Glunde; Melanie Galla; Axel Schambach; Peter Cherepanov; Thomas F Schulz
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

8.  ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment.

Authors:  Hetal Patel; Manikandan Periyasamy; Georgina P Sava; Alexander Bondke; Brian W Slafer; Sebastian H B Kroll; Marion Barbazanges; Richard Starkey; Silvia Ottaviani; Alison Harrod; Eric O Aboagye; Laki Buluwela; Matthew J Fuchter; Anthony G M Barrett; R Charles Coombes; Simak Ali
Journal:  Mol Cancer Ther       Date:  2018-03-15       Impact factor: 6.261

9.  Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development.

Authors:  Pan Tang; Jifa Zhang; Jie Liu; Cheng-Ming Chiang; Liang Ouyang
Journal:  J Med Chem       Date:  2021-02-22       Impact factor: 7.446

10.  BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.

Authors:  Daniela Boehm; Vincenzo Calvanese; Roy D Dar; Sifei Xing; Sebastian Schroeder; Laura Martins; Katherine Aull; Pao-Chen Li; Vicente Planelles; James E Bradner; Ming-Ming Zhou; Robert F Siliciano; Leor Weinberger; Eric Verdin; Melanie Ott
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.